Global Med Technologies, Inc.'s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will D
September 17 2009 - 12:37PM
PR Newswire (US)
New RFID Product is Estimated to be a $1 Billion 'Green Field'
Market Opportunity Internationally and is Expected to Generate
Significant Revenues and Profits DENVER, Sept. 17
/PRNewswire-FirstCall/ -- Global Med Technologies , Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international healthcare information technology company, today
announced that Michael I. Ruxin, M.D., Global Med's Chairman and
CEO, will make a major new product announcement the morning of the
LDV Growth & Value Equity Conference which will be held at The
Embassy Suites Boca Raton Hotel, Boca Raton, Florida. Dr. Ruxin
will also demo the breakthrough product at the conference. To RSVP
and arrange one-on-one private sessions, please call James DePelisi
at (954) 746-3117 or email: . (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) The
breakthrough medical product announcement will be concerning an
innovative, European RFID medical device, that has just come on the
market, and that has little competition with older medical device
technologies that currently exist in the same area. Market
penetration of these older medical devices is less than 10% in the
U.S. market and has minimal penetration in international markets.
The main reasons for the small market penetration globally are the
high cost of these older medical devices, lengthy staff education
needed to implement, and overall difficulty of use. Global Med's
new RFID product will overcome all three of these concerns. The
product is currently not for sale in the U.S., but is being sold in
Europe. Global Med intends to apply for FDA clearance of the
product in the near future. About Global Med Technologies , Inc.
Global Med Technologies, Inc. is an international healthcare
information technology company which develops regulated and
non-regulated products and services for the healthcare industry. As
a leading provider of blood and laboratory systems and services,
Global Med's products are deployed in 20 countries and serve over
2,100 transfusion centers, blood banks and laboratory sites. Global
Med's domestic companies are Wyndgate Technologies , a leader in
software products and services for donor centers and hospital
transfusion services; eDonor , which offers web-based donor
relationship management systems; and PeopleMed(TM), Inc., which
implements cost-effective software validation, consulting and
compliance solutions to hospitals and donor centers. Global Med's
European subsidiary, Inlog, SA, is a leading developer of *donor
center and *transfusion management systems as well as cellular
therapy software, *laboratory information systems and quality
assurance medical software systems internationally. *Products are
not marketed in the United States. For more information about
Global Med's products and services, please call 800-996-3428 or
visit http://www.globalmedtech.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or Investors, Jeffrey Benison of Little
Gem Life Science Partners, +1-212-334-8709, , for Global Med
Technologies, Inc. Web Site: http://www.globalmedtech.com/
Copyright